2 research outputs found
Efficacy of Breast Ultrasonography for Detection of Local, Regional, and Contralateral Recurrence of Breast Cancer
Purpose: Breast uttrasonography (US) is not recommended for recurrence monitoring after breast cancer surgery due to the lack of evidence for its advantage. The purpose of this study was to evaluate the usefulness of US for detecting local recurrence (LR), regional recurrence (RR) and contralateral breast cancer (CBC) in breast cancer patients during follow-up. Methods: The medical records of 5,833 breast cancer patients who underwent breast cancer surgery between January 2003 and December 2009 were reviewed retrospectively. Physical examination (PE), mammography (MMG), and US were done routinely to detect recurrences. Detection rate for locoregional and contralateral recurrence was compared between the three modalities. Results: During the follow-up period, 125 LR, 46 RR, 83 CBC, and 29 synchronous local and regional recurrences developed in 245 patients among the study population of 5,833 breast cancer patients. Median time to recurrence was 34.7 months. The recurrence detection rate was 51.9%, 43.5%, and 90.1% for PE, MMG, and US, respectively. Mean size of the recurrent lesions detected by US (1.57 cm) was smaller than that of PE (2.69 cm) and MMG (2.03 cm) (p=0.002). Conclusion: Breast US had higher recurrence detection rate for LA, RR, and CBC than PE or MMG after breast cancer surgery.
μ λ°©μμ 2007λ
μ°λ¦¬λλΌ μ¬μ± μ λ°μλ₯ 2μ(15.1%), λ°μ νμ μλ 11,606λͺ
μ μ°¨μ§νκ³ μκ³ , μ°κ° 6,6%μ λμ λ°μλ₯ μ μ¦κ°λ₯Ό 보μ΄κ³ μλ€.(1) λν μ§λ 10λ
κ° κ΅λ΄μ μ λ°©μ μΉλ£ μ±μ λ μ§μμ μΌλ‘ κ°μ λμ΄ 5λ
μμ‘΄μ¨μ 77.9%μμ 89.5%λ‘
11.5% μ¦κ°νμλ€. μ΄λ¬ν μ λ³λ₯ μ μ¦κ°μ μ₯κΈ° μμ‘΄μ¨μ ν₯μμΌλ‘ μΈν΄ 1999λ
μ΄ν 9λ
λμ μ λ³μ μλ 68,136λͺ
(11.2%)μΌλ‘ λΉ λ₯΄κ² μ¦κ°νκ³ μλ€.(1,2) μ΄λ¬ν μ λ°©μ λ°μλ₯ μ¦κ°μ μ¬λ§λ₯ κ°μ λ° μ λ°©μ μμ ν μ₯κΈ°μμ‘΄μμ μ¦κ°μ λ°λΌ λμΈ‘ μ λ°© λ΄ μ¬λ°μ ν¬ν¨ν κ΅μμ¬λ°κ³Ό λ°λμΈ‘ μ λ°©μμ΄ λ°μνλ νμμ λΉλκ° μ΅κ·Ό μ¦κ°νκ³ μλ€.
National Surgical Adjuvant Breast and Bowel Project(NSABP) B-06μ κ²½μ° 20λ
μ μΆμ κ΄μ°°κΈ°κ° λμ 14.3%μ λμΈ‘ μ λ°© μ¬λ°(ipsilateral breast tumor recurrence)μ λ³΄κ³ νμκ³ ,(3) 10λ
μ μΆμ κΈ°κ° λμ λ¨λ
κ΅μ-ꡬμ μ¬λ°(locoregional recurrence)μ 12.4%, 4κ°μ μ΄λ΄ μ μ μ¬λ°μ λλ°ν κ΅μ-ꡬμ μ¬λ°μ 19.8% λ³΄κ³ λμλ€.(4) μ λ°©μμΌλ‘ μΉλ£λ°μ νμμμ λ°λμΈ‘ μ λ°©μ(contralateral breast cancer)μ΄ μκΈΈ νλ₯ μ 2-11%λ‘ μ λ°©μμ κ±Έλ¦¬μ§ μμ μ¬μ±μ λΉν΄ 2-6λ°°μ λμ μνλλ₯Ό κ°μ§λ€.(5)
2008λ
νκ΅μ λ°©μνν μ λ°©μ μ§λ£κΆκ³ μμ λΉλ‘―νμ¬ μꡬμ λ€μν μ λ°©μ μ§λ£κΆκ³ μμμλ κ΅μ, ꡬμ, κ·Έλ¦¬κ³ λ°λμΈ‘ μ λ°©μ μ¬λ°μ μ§λ¨ν¨μ μμ΄μ 1λ
λ§λ€μ μΆμ κ΄μ°°κ³Ό ν¨κ» μ 방촬μμ μ μννλ κ²μ κΆκ³ νκ³ μλ€. κ·Έλ¬λ μ λ°©μ΄μνλ μ λ°© μ기곡λͺ
μμ λ±μ μΆκ°μ μμκ²μ¬μ ν¨μ©μ μμ§ λΆνμ€νμ¬ κ³ μν νμμμ μ νμ μΌλ‘ μννλ κ²μ κΆνκ³ μλ€.(6-11)μ΅κ·Ό μ¬λ¬ κ΅λ΄μΈμ μ°κ΅¬μμ μ λ°©μ μμ ν κ΅μμ¬λ°μ΄λ μ‘μλΆ λ¦Όνμ μ¬λ°μ μ‘°κΈ° λ°κ²¬νλ λ° μμ΄ μ λ°©μ΄μνμ μ μ¬μ ν¨μ©μ±μ΄ λ³΄κ³ λκ³ μλ€.(12-15) μ΄μ λ³Έ μ°κ΅¬μμλ μ λ°©μμ κ΅μ, ꡬμ, κ·Έλ¦¬κ³ λ°λμΈ‘ μ λ°©μ μ¬λ°μ μ§λ¨νλ λ° μμ΄μ μ λ°©
μ΄μνμ μ μ©μ±μ λ¨μΌκΈ°κ΄μμ μμ λ°κ³ μΆμ κ΄μ°°λ°μ νκ΅μΈ μ λ°©μ νμκ΅°μμ λΆμν΄λ³΄κ³ μ νμλ€.λ³Έ λ
Όλ¬Έμ 2010λ
λ μ λΆ(κ΅μ‘κ³ΌνκΈ°μ λΆ)μ μ¬μμΌλ‘ νκ΅μ°κ΅¬μ¬λ¨μ κΈ°μ΄
μ°κ΅¬μ¬μ
μ§μμ λ°μ μνλ κ²μ(2010-0004148).Kelly KM, 2010, EUR RADIOL, V20, P2557, DOI 10.1007/s00330-010-1844-1Kim HJ, 2010, ANN SURG ONCOL, V17, P2670, DOI 10.1245/s10434-010-1087-zJung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113Aebi S, 2010, ANN ONCOL, V21, pv9, DOI 10.1093/annonc/mdq159Lehman CD, 2009, J NATL COMPR CANC NE, V7, P1109Houssami N, 2009, ANN ONCOL, V20, P1505, DOI 10.1093/annonc/mdp037Moon HJ, 2009, RADIOLOGY, V252, P673, DOI 10.1148/radiol.2523081977Yarnold J, 2009, CLIN ONCOL-UK, V21, P159, DOI 10.1016/j.clon.2008.12.008Kim MJ, 2009, AM J ROENTGENOL, V192, P221, DOI 10.2214/AJR.07.4048Montgomery DA, 2007, BRIT J CANCER, V96, P1802, DOI 10.1038/sj.bjc.6603815Yilmaz MH, 2007, DIAGN INTERV RADIOL, V13, P13Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575Shin JH, 2005, J ULTRAS MED, V24, P643Taghian A, 2004, J CLIN ONCOL, V22, P4247, DOI 10.1200/JCO.2004.01.042Ciatto S, 2004, EUR J CANCER, V40, P1496, DOI 10.1016/j.ejca.2004.03.010Fisher B, 2002, NEW ENGL J MED, V347, P1233KIM SH, 2000, J KOREAN RADIOL SOC, V42, P1009Chen Y, 1999, CANCER EPIDEM BIOMAR, V8, P855GORDON PB, 1995, CANCER, V76, P626GIUSEPPETTI GM, 1989, RADIOL MED, V78, P339*NAT COMPR CANC NE, NCCN CLIN PRACT GUID*AM COLL RAD, ACR BREAST IM REP DA*NAT CANC INF CTR, CANC STAT*KOR BREAST CANC S, 3 BREAST CANC MAN RE
Dynamic contrast-enhanced MRI of abscess and VX2 carcinoma in rabbits : comparison of 24 gadolinium-DOTA-dendrimer and gadopentetate dimeglumine ν λΌμμ λμκ³Ό VX2 μμ’ μ μλμ± μ‘°μμ¦κ° MRI: 24 gadolinium-DOTA-dendrimerμ gadopentetate dimeglumineμ λΉκ΅
Thesis (doctoral)--μμΈλνκ΅ λνμ :μνκ³Ό λ°©μ¬μ κ³Όνμ 곡,1999.Docto